
Pharma News5 min
J&J's Talvey-Darzalex Combo Advances Multiple Myeloma Treatment Timeline
MonumenTAL-3 phase 3 trial demonstrates efficacy of bispecific antibody combination in earlier-stage multiple myeloma, earning plenary presentation at EHA 2026.
Read







